RELT Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of RELT Antibodies for various research applications. RELT Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RELT, or receptor expression enhancing protein, plays a significant role in modulating immune responses and influences various cellular processes, including apoptosis and inflammation. Understanding RELT function is essential for elucidating its involvement in disease mechanisms and potential therapeutic targets. Research focusing on RELT expression has revealed important insights into cancer development and autoimmune disorders, highlighting its impact on disease progression. Investigating RELT signaling pathways has opened new avenues for understanding cellular communication and immune system regulation. Advanced research techniques have demonstrated RELT's influence on cell survival and inflammatory responses. Current studies continue to uncover novel aspects of RELT's biological functions and their implications for human health. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of RELT's role in cellular processes and disease mechanisms.